Novartis
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
UK's GSK to acquire U.S. drugmaker Nuvalent for $10.6 billion as pharma giants race to expand pipelines
U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based drugmaker Nuvalent for $10.6 billion to bolster its lung cancer pipeline, in what would be the British drugmaker's largest acquisition in more than a decade. The all-cash deal values Nuvalent at about $124 per share, according to a GSK filing on Tuesday, representing a 40% premium to its last closing price. The Financial Times had reported the transaction earlier on Tuesday.
Platner’s anti-corporate crusade hits awkward snag as receipts tell another story
Maine Democratic Senate candidate Graham Platner built a national reputation as an anti-corporate crusader while cashing checks written by lobbyists and executives representing those same corporations, campaign finance documents show. Platner has made criticism of big tech, the pharmaceutical industry, large banks and defense contractors a cornerstone of his campaign to unseat incumbent GOP Sen. Susan Collins. Federal Election Commission and Lobbying Disclosure Act records reviewed by Fox...
Platner’s anti-corporate crusade hits awkward snag as receipts tell another story
Maine Democratic Senate candidate Graham Platner built a national reputation as an anti-corporate crusader while cashing checks written by lobbyists and executives representing those same corporations, campaign finance documents show. Platner has made criticism of big tech, the pharmaceutical industry, large banks and defense contractors a cornerstone of his campaign to unseat incumbent GOP Sen. Susan Collins. Federal Election Commission and Lobbying Disclosure Act records reviewed by Fox...